Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (421-430 of 501) with videos related to

Pageof 51
Sort By:
Internal Medicine Journal|July 28, 2011
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?M H Lee, S L Stocker, J Anderson, et al.
BMJ Open|January 21, 2012
CareTrack Australia: assessing the appropriateness of adult healthcare: protocol for a retrospective medical record reviewTamara D Hunt, Shanthi A Ramanathan, Natalie A Hannaford, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
BMJ (Clinical Research Ed.)|April 2, 2015
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trialsGustavo C Machado, Chris G Maher, Paulo H Ferreira, et al.
Annals of the Rheumatic Diseases|February 3, 2016
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urateDiluk R W Kannangara, Amanda J Phipps-Green, Nicola Dalbeth, et al.
Clinical and Experimental Rheumatology|November 1, 1989
Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular routeP N Sambrook, G D Champion, C D Browne, et al.
Clinical Pharmacokinetics|December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation StudyMelanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
European Journal of Clinical Pharmacology|July 14, 2023
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022)Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, et al.
Lancet (London, England)|July 1, 2023
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trialCaitlin M P Jones, Richard O Day, Bart W Koes, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
Pageof 51

Showing results (421-430 of 501) with videos related to

Sort By:
Pageof 51
Internal Medicine Journal|July 28, 2011
Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?M H Lee, S L Stocker, J Anderson, et al.
BMJ Open|January 21, 2012
CareTrack Australia: assessing the appropriateness of adult healthcare: protocol for a retrospective medical record reviewTamara D Hunt, Shanthi A Ramanathan, Natalie A Hannaford, et al.
British Journal of Clinical Pharmacology|June 8, 2022
Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptionsMatthew J Coleshill, Richard O Day, Karson Tam, et al.
BMJ (Clinical Research Ed.)|April 2, 2015
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trialsGustavo C Machado, Chris G Maher, Paulo H Ferreira, et al.
Annals of the Rheumatic Diseases|February 3, 2016
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urateDiluk R W Kannangara, Amanda J Phipps-Green, Nicola Dalbeth, et al.
Clinical and Experimental Rheumatology|November 1, 1989
Corticosteroid injection for osteoarthritis of the knee: peripatellar compared to intra-articular routeP N Sambrook, G D Champion, C D Browne, et al.
Clinical Pharmacokinetics|December 18, 2024
Relative Forgiveness of Different Allopurinol Implementation Patterns in People with Gout and their Impact on Clinical Outcomes: a Simulation StudyMelanie White-Koning, Daniel F B Wright, Dyfrig A Hughes, et al.
European Journal of Clinical Pharmacology|July 14, 2023
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022)Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, et al.
Lancet (London, England)|July 1, 2023
Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trialCaitlin M P Jones, Richard O Day, Bart W Koes, et al.
British Journal of Clinical Pharmacology|April 18, 2013
Understanding the dose-response relationship of allopurinol: predicting the optimal dosageGarry G Graham, Diluk R W Kannangara, Sophie L Stocker, et al.
Pageof 51